PhotoPharmics' Unattributed VC Round

PhotoPharmics raised a round of funding on February 10, 2017. Investors include Kickstart Seed Fund.

PhotoPharmics provides specialized phototherapy which allows dopamine to be assimilated by Parkinson's patients. A number of trials, including a 4-year, 130 patient study, demonstrate dramatic symptom…

Articles about PhotoPharmics' Unattributed VC Round: